+ All Categories
Home > Education > UCSF Life Sciences Week 2 Diagnostics

UCSF Life Sciences Week 2 Diagnostics

Date post: 29-Jun-2015
Category:
Upload: steve-blank
View: 44,600 times
Download: 1 times
Share this document with a friend
Popular Tags:
24
Customer Segmentation Diagnostics Cohort D-1 UCSF Lean LaunchPad For Life Sciences October 8, 2013 Todd Morrill 1
Transcript
Page 1: UCSF Life Sciences Week 2 Diagnostics

1

Customer SegmentationDiagnostics Cohort D-1

UCSF Lean LaunchPad For Life SciencesOctober 8, 2013

Todd Morrill

Page 2: UCSF Life Sciences Week 2 Diagnostics

Customer interviews

Page 3: UCSF Life Sciences Week 2 Diagnostics

Customer interviews

• Draw them out• Don’t worry about money• Use google to find prospects• Don’t piss me off

Page 4: UCSF Life Sciences Week 2 Diagnostics

Today

• Value Proposition

• BMC fit and fitness

• What is a Customer Segment

• Our cross to bear…

Page 5: UCSF Life Sciences Week 2 Diagnostics

5

Value Propositions are NOT complex

• More accurate results, faster!• Higher sensitivity with less sample volume• Accurate ranking of treatment options• Easy-to-use cosmic ray gun• Portable nuclear warhead

But the environment is…

• VP maps onto CS• No Value Proposition, no Customer Segment• Too many value propositions, not a Customer Segment

• VPs for each ‘customer’ in the ecosystem, to the extent possible

Page 6: UCSF Life Sciences Week 2 Diagnostics

6

How we will fit DX into the BMC

REGULATION

CLINICAL TRIALS

IPREIMBURSEMENT

Page 7: UCSF Life Sciences Week 2 Diagnostics

Who is a Customer?

• Someone who has a NEED which can be satisfied by your VPs• Someone who has a WANT which can be satisfied• Someone who can be IDENTIFIED• Someone who can be DIFFERENTIATED

Page 8: UCSF Life Sciences Week 2 Diagnostics

© 2012 Steve Blank

Page 9: UCSF Life Sciences Week 2 Diagnostics

Joe “Dude” Marrama

• Loves to ski, surf, rock climb• Salary ~100K/year• Looking for something to do

when the surf’s blown out• Intimidated by cost and learning

curve of kiting

“Companies need to offer more entry level packages."

Matt SextonFounder Collegiate Kiteboarding Association

Customer Archetype:

Page 10: UCSF Life Sciences Week 2 Diagnostics

Our Customers• Professional Kite Surfers

• Solely concerned with performance

• Average Kite Surfer• Performance and cost sensitive• “One less thing to carry” effect

• Prospective Kite Surfer• Cost sensitive• Learning barrier

Results:

Page 11: UCSF Life Sciences Week 2 Diagnostics

Meet Xing Xie

• Engineering graduate student– Receives financial package to cover tuition, fees,

insurance and living expenses

• Chinese 4-2-1 family– No siblings, spoiled by parents– High disposable income

• 1st time to America– No credit score, SSN, or US address– Strong ties to his community in China

• Academically responsible – Completes all homework on time

• Financially responsible– Pays all bills on time and in full

• Social network is similarly responsible

ArtXing

International Graduate Student at Stanford

Page 12: UCSF Life Sciences Week 2 Diagnostics

12

Customer Segments?

• Kids• Boys• Adults

• Kids under 10 with disposable income (and who are thirsty)

• Boys who like to watch machines working, like the juicer machine

• Dads and Moms who are walking past our stand in the afternoon

xConsider ‘Un-customer segments’

Page 13: UCSF Life Sciences Week 2 Diagnostics

Good segmentation?

Need vs Want

Page 14: UCSF Life Sciences Week 2 Diagnostics

Definitions: Four Types of Markets

• Existing Market– Faster/Better = High end

• Resegmented Market– Niche = marketing/branding driven– Cheaper = low end

• New Market– Cheaper/good enough can create a new class of

product/customer– Innovative/never existed before

• Clone Market• Local adaptation

Existing Market

Resegmented Market

New Market

Clone Market

Page 15: UCSF Life Sciences Week 2 Diagnostics

Because you are here..

Page 16: UCSF Life Sciences Week 2 Diagnostics

16

Because you are special…hypothesize now

REGULATION

CLINICAL TRIALS

IPREIMBURSEMENT

Page 17: UCSF Life Sciences Week 2 Diagnostics

Know your regulator

• Food and Drug Administration (FDA)– Center for Devices and Radiological Health

• USDA• European agencies (EMEA, national level)• Japanese Ministry of Health and Welfare• Chinese (SFDA)• Health Canada

Page 18: UCSF Life Sciences Week 2 Diagnostics

Regulation

• In vitro diagnostic products (IVD) are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body. [21 CFR 809.3]

• IVDs are medical devices as defined in section 210(h) of the Federal Food, Drug, and Cosmetic Act, and may also be biological products subject to section 351 of the Public Health Service Act. Like other medical devices, IVDs are subject to premarket and postmarket controls. IVDs are also subject to the Clinical Laboratory Improvement Amendments (CLIA '88) of 1988.

• What isn’t an IVD?– In vivo– Treatments

Page 19: UCSF Life Sciences Week 2 Diagnostics

Regulatory classes for diagnostics

• Class I (low to moderate risk): general controls

• Class II (moderate to high risk): general controls and Special Controls (510(k)) aka PMN– Performance standards– Postmarket surveillance– Patient registries– Special labeling requirements– Premarket data requirements

• Class III (high risk): general controls and Premarket Approval (PMA)– Under federal law, class III devices are subject to approval of a Premarket Approval Application (PMA).– Devices that are not within a type marketed before the date of the Medical Device Amendments of 1976 –

referred to preamendments devices – are classified into class III automatically under federal law.. In addition, the FDA classifies into class III devices intended to be used in supporting or sustaining human life or preventing impairment of human health, or that may present a potential unreasonable risk of illness or injury for which general controls and special controls are insufficient to provide reasonable assurance of the safety and effectiveness of a device, or for which there is insufficient information to make such a determination.

http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/GeneralandSpecialControls/ucm2005378.htm#class_1

Page 20: UCSF Life Sciences Week 2 Diagnostics

Believe it or not…

Regulators are part of your customer set

1. Find out which regulator and sub-agency is likely to be yours

2. Find out the process for regulation and validation

3. Map them into your ecosystem

Page 21: UCSF Life Sciences Week 2 Diagnostics

Who pays for healthcare?

Page 22: UCSF Life Sciences Week 2 Diagnostics

What is Reimbursement?

• Reimbursement for procedures and services performed by providers is made by commercial payers or federal intermediaries acting on behalf of a half-dozen programs. Reimbursement is based on claims and documentation filed by providers using medical diagnosis and procedure codes.

• Commercial payers must use standards defined by the U.S. Department of Health and Human Services (HHS) but are largely regulated state-by-state. Save for specific national mandates such as reimbursement for childbirth, commercial payers determine their own rules of medical necessity or payment and reimbursement fee schedules. Federal intermediaries are regulated as contractors by the Centers for Medicare & Medicaid Services (CMS).

• The Current Procedural Terminology (CPT) code set is a medical code set maintained by the American Medical Association. The CPT code set (copyright protected by the AMA) describes medical, surgical, and diagnostic services and is designed to communicate uniform information about medical services and procedures among physicians, coders, patients, accreditation organizations, and payers for administrative, financial, and analytical purposes

Page 23: UCSF Life Sciences Week 2 Diagnostics

Like it or not…

Reimbursers and code allocators are part of your customer set

1. Find out which code groups you may fit into

2. Find out the value for them3. Find out the process for

assignment and approval4. Map them into your

ecosystem

Page 24: UCSF Life Sciences Week 2 Diagnostics

Next week

• Standard slides as per the syllabus• Plus

– Ecosystem overview– Regulation overview– Reimbursement overview


Recommended